Tags

Type your tag names separated by a space and hit enter

[Surgical treatment of malignant eyelid tumors].
Pol Merkur Lekarski. 2013 Apr; 34(202):214-8.PM

Abstract

Eyelid tumors constitute 5 to 10% of all skin malignancies. They mostly affect the elderly, chronically exposed to sunlight. The primary treatment is radical surgical excision of the tumor. The aim of this study was the clinical and microscopical analysis of malignant eyelid tumors in treated patients, the presentation of selected reconstructive methods and the evaluation of long-term results of surgical treatment of eyelid tumors.

MATERIAL AND METHODS

The study involved 92 patients treated in 2000-2007 for malignant tumors of the eyelids. All patients underwent surgical excision of the tumor with concurrent eyelid reconstruction. The choice of reconstructive method depended on the size and location of the tumor. Histopathological evaluation was carried out specifying the type of cancer and radical surgery. The long-term results were rated on the basis of medical records and patients' examinations.

RESULTS

Tumors were located mostly within the lower eyelid 67 (70.5%) and the medial canthus 17 (17.9%). Basal cell carcinoma was found in 83 (87.3%) cases, while in 12 (12.7%) diagnosed with other, less common cancers. Histopathological verification of tumor margins revealed incomplete excision in 14 specimens (14.7%). Reoperations due to recurrent tumor was performed in 11 (15.6%) cases. Good long-term results of functionally-aesthetic reconstruction of the eyelids was observed in 84 (91.3%) patients.

CONCLUSIONS

1. Basal cell carcinoma is the most common malignant tumor of the oculopalpebral region and originate mainly in the lower eyelid. 2. Significantly higher risk of recurrence exists in a more aggressive form of BCC (infiltrative basal-cell carcinoma) and tumors located in medial canthus. 3. The knowledge of multiple reconstruction methods allows the surgeon to choose the most appropriate one, depending on the size and location of the defect formed after excision of the tumor.

Authors+Show Affiliations

Uniwersytet Medyczny w Łodzi, Klinika Chirurgii Plastycznej, Rekonstrukcyjnej i Estetycznej. tomziel@onet.euNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

English Abstract
Journal Article

Language

pol

PubMed ID

23745328

Citation

Zieliński, Tomasz, et al. "[Surgical Treatment of Malignant Eyelid Tumors]." Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego, vol. 34, no. 202, 2013, pp. 214-8.
Zieliński T, Pisera P, Siewiera I, et al. [Surgical treatment of malignant eyelid tumors]. Pol Merkur Lekarski. 2013;34(202):214-8.
Zieliński, T., Pisera, P., Siewiera, I., Sporny, S., & Iljin, A. (2013). [Surgical treatment of malignant eyelid tumors]. Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego, 34(202), 214-8.
Zieliński T, et al. [Surgical Treatment of Malignant Eyelid Tumors]. Pol Merkur Lekarski. 2013;34(202):214-8. PubMed PMID: 23745328.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Surgical treatment of malignant eyelid tumors]. AU - Zieliński,Tomasz, AU - Pisera,Paweł, AU - Siewiera,Ireneusz, AU - Sporny,Stanisław, AU - Iljin,Aleksandra, PY - 2013/6/11/entrez PY - 2013/6/12/pubmed PY - 2013/8/9/medline SP - 214 EP - 8 JF - Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego JO - Pol Merkur Lekarski VL - 34 IS - 202 N2 - UNLABELLED: Eyelid tumors constitute 5 to 10% of all skin malignancies. They mostly affect the elderly, chronically exposed to sunlight. The primary treatment is radical surgical excision of the tumor. The aim of this study was the clinical and microscopical analysis of malignant eyelid tumors in treated patients, the presentation of selected reconstructive methods and the evaluation of long-term results of surgical treatment of eyelid tumors. MATERIAL AND METHODS: The study involved 92 patients treated in 2000-2007 for malignant tumors of the eyelids. All patients underwent surgical excision of the tumor with concurrent eyelid reconstruction. The choice of reconstructive method depended on the size and location of the tumor. Histopathological evaluation was carried out specifying the type of cancer and radical surgery. The long-term results were rated on the basis of medical records and patients' examinations. RESULTS: Tumors were located mostly within the lower eyelid 67 (70.5%) and the medial canthus 17 (17.9%). Basal cell carcinoma was found in 83 (87.3%) cases, while in 12 (12.7%) diagnosed with other, less common cancers. Histopathological verification of tumor margins revealed incomplete excision in 14 specimens (14.7%). Reoperations due to recurrent tumor was performed in 11 (15.6%) cases. Good long-term results of functionally-aesthetic reconstruction of the eyelids was observed in 84 (91.3%) patients. CONCLUSIONS: 1. Basal cell carcinoma is the most common malignant tumor of the oculopalpebral region and originate mainly in the lower eyelid. 2. Significantly higher risk of recurrence exists in a more aggressive form of BCC (infiltrative basal-cell carcinoma) and tumors located in medial canthus. 3. The knowledge of multiple reconstruction methods allows the surgeon to choose the most appropriate one, depending on the size and location of the defect formed after excision of the tumor. SN - 1426-9686 UR - https://www.unboundmedicine.com/medline/citation/23745328/[Surgical_treatment_of_malignant_eyelid_tumors]_ DB - PRIME DP - Unbound Medicine ER -